BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32250239)

  • 1. Point of care testing of Influenza A/B and RSV in an adult respiratory assessment unit is associated with improvement in isolation practices and reduction in hospital length of stay.
    Berry L; Lansbury L; Gale L; Carroll AM; Lim WS
    J Med Microbiol; 2020 May; 69(5):697-704. PubMed ID: 32250239
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Rapid Molecular Diagnostic Testing of Respiratory Viruses on Outcomes of Adults Hospitalized with Respiratory Illness: a Multicenter Quasi-experimental Study.
    Wabe N; Li L; Lindeman R; Yimsung R; Dahm MR; McLennan S; Clezy K; Westbrook JI; Georgiou A
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study.
    Rahamat-Langendoen J; Groenewoud H; Kuijpers J; Melchers WJG; van der Wilt GJ
    J Med Virol; 2019 Aug; 91(8):1408-1414. PubMed ID: 30950066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Influenza A and B Viruses and Respiratory Syncytial Virus by Use of Clinical Laboratory Improvement Amendments of 1988 (CLIA)-Waived Point-of-Care Assays: a Paradigm Shift to Molecular Tests.
    Azar MM; Landry ML
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29695519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-center evaluation of the cobas
    Gibson J; Schechter-Perkins EM; Mitchell P; Mace S; Tian Y; Williams K; Luo R; Yen-Lieberman B
    J Clin Virol; 2017 Oct; 95():5-9. PubMed ID: 28818691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using a novel rapid viral test to improve triage of emergency department patients with acute respiratory illness during flu season.
    Pedersen CJ; Rogan DT; Yang S; Quinn JV
    J Clin Virol; 2018 Nov; 108():72-76. PubMed ID: 30261422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in turnaround time for rapid respiratory virus testing using Xpert® Flu/RSV: a retrospective cohort study during a high incidence influenza season.
    Williams E; Dennison A; Jenney AW; Spelman DW
    Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114869. PubMed ID: 31473035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care tests for influenza A and B viruses and RSV in emergency departments - indications, impact on patient management and possible gains by syndromic respiratory testing, Capital Region, Denmark, 2018.
    Schneider UV; Holm MKA; Bang D; Petersen RF; Mortensen S; Trebbien R; Lisby JG
    Euro Surveill; 2020 Nov; 25(44):. PubMed ID: 33153518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel PCR-based point-of-care method facilitates rapid, efficient, and sensitive diagnosis of influenza virus infection.
    Schmidt RLJ; Simon A; Popow-Kraupp T; Laggner A; Haslacher H; Fritzer-Szekeres M; Redlberger-Fritz M; Mayer FJ
    Clin Microbiol Infect; 2019 Aug; 25(8):1032-1037. PubMed ID: 30583060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a rapid automated influenza A, influenza B, and respiratory syncytial virus A/B multiplex real-time RT-PCR assay and its use during the 2009 H1N1 swine-origin influenza virus epidemic in Milwaukee, Wisconsin.
    Beck ET; Jurgens LA; Kehl SC; Bose ME; Patitucci T; LaGue E; Darga P; Wilkinson K; Witt LM; Fan J; He J; Kumar S; Henrickson KJ
    J Mol Diagn; 2010 Jan; 12(1):74-81. PubMed ID: 19959800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study.
    Garvey MI; Wilkinson MAC; Bradley CW; Biggs M; Reddy-Kolanu V; Osman H; Carmalt S; Holden E
    Antimicrob Resist Infect Control; 2019; 8():120. PubMed ID: 31346461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter Clinical Evaluation of the Luminex Aries Flu A/B & RSV Assay for Pediatric and Adult Respiratory Tract Specimens.
    Juretschko S; Mahony J; Buller RS; Manji R; Dunbar S; Walker K; Rao A
    J Clin Microbiol; 2017 Aug; 55(8):2431-2438. PubMed ID: 28539342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.
    Cohen DM; Kline J; May LS; Harnett GE; Gibson J; Liang SY; Rafique Z; Rodriguez CA; McGann KM; Gaydos CA; Mayne D; Phillips D; Cohen J
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lower respiratory tract infections with influenza and respiratory syncytial viruses in hospitalized elderly patients during the 2005-2006 winter season].
    Haber N; Dekimeche S; Cantet C; Marquand D; Szekely C; Lebon P
    Presse Med; 2009 Jun; 38(6):893-903. PubMed ID: 19097850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens.
    Ho YII; Wong AH; Lai RWM
    J Med Microbiol; 2018 Nov; 67(11):1576-1580. PubMed ID: 30207514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of implementing respiratory point-of-care testing in a regional haemato-oncology unit.
    Goldstein EJ; Dhillon R; McCullough C; Inkster T; Soutar R; Gunson RN
    J Hosp Infect; 2020 Sep; 106(1):20-24. PubMed ID: 32569673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of a Novel Point-of-Care Molecular Assay for Detection of Influenza A and B Viruses and Respiratory Syncytial Virus (Enigma MiniLab) in Children with Acute Respiratory Infection.
    Douthwaite ST; Walker C; Adams EJ; Mak C; Vecino Ortiz A; Martinez-Alier N; Goldenberg SD
    J Clin Microbiol; 2016 Jan; 54(1):212-5. PubMed ID: 26560540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.
    Clark TW; Beard KR; Brendish NJ; Malachira AK; Mills S; Chan C; Poole S; Ewings S; Cortes N; Nyimbili E; Presland L
    Lancet Respir Med; 2021 Apr; 9(4):419-429. PubMed ID: 33285143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use.
    Andrews D; Chetty Y; Cooper BS; Virk M; Glass SK; Letters A; Kelly PA; Sudhanva M; Jeyaratnam D
    BMC Infect Dis; 2017 Oct; 17(1):671. PubMed ID: 29017451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study.
    To KKW; Yip CCY; Lai CYW; Wong CKH; Ho DTY; Pang PKP; Ng ACK; Leung KH; Poon RWS; Chan KH; Cheng VCC; Hung IFN; Yuen KY
    Clin Microbiol Infect; 2019 Mar; 25(3):372-378. PubMed ID: 29906597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.